[spacer image]
BD
[spacer image]
BD Stock Price
Annual Reports / Proxy
[spacer image]
Contact Us / Request Information
[spacer image]
Corporate Governance
[spacer image]
Events
[spacer image]
FAQs
[spacer image]
Financial Information
[spacer image]
Investor Alerts
[spacer image]
Press Releases
[spacer image]
SEC Filings / Section 16 Reports
[spacer image]
Stock Information
[spacer image]
Worldwide Business Segments
[spacer image]
[spacer image]

Did you know?
[spacer image] Fairleigh Dickinson was issued a patent for the BD Luer-Lok™ syringe in 1925. Learn more about BD's history » [spacer image]
[spacer image]

A strong base in proprietary technology makes BD a leading provider of medical products for medication delivery, blood collection, diagnostic testing, flow cytometry, infusion therapy, surgery, anesthesia delivery, ophthalmology, critical care, immunization, sharps disposal and medication management. BD offers a wide array of products (syringes, needles, blood collection devices, IV catheters, surgical instruments) with advanced protection features to help healthcare workers avoid injury.
[spacer image]

News & Events

[bullet] BD to Present at Investor Healthcare Conferences »
[bullet] BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases  »
[bullet] BD Announces Results for Fourth Fiscal Quarter and Full Year »
[bullet] BD Announces Executive Appointments of President and Chief Financial Officer »
[bullet] BD to Present at Investor Healthcare Conferences »
[bullet] BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call »
[bullet] BD Board Declares Dividend »
[spacer image] Learn More About...
 
  BD Business Segments
 
   [bullet] BD Medical

     - Medical Surgical
          - Anesthesia Products
          - Infusion Therapy Products
          - Injection Products
          - Sharps Disposal Products
          - Surgical Products
     - Diabetes Care
          - Diabetes Care Products
          - Sports Injury Treatment
             Products
          - Thermometers
     - Ophthalmic Systems
     - Pharmaceutical Systems  

   [bullet] BD Diagnostics

     - Diagnostic Systems
     - Preanalytical Systems
  

   [bullet] BD Biosciences

     - Cell Analysis
     - Discovery Labware


  BD Ventures
 
BD Ventures, L.L.C. operates a $40 million venture capital fund and is wholly-owned by BD. BD Ventures actively seeks early-stage investment opportunities from a variety of sources. »

 


 [spacer image]

[spacer image] [spacer image]

[spacer image]


[spacer image] BD Selected as Component of Dow Jones Sustainability World Index »
 [spacer image]

[spacer image]


[spacer image] [spacer image]

[spacer image]

  Updated March 2008
[spacer image]   Updated March 2008
 [spacer image]
[spacer image]
[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]
Site Map
Privacy | Terms & Conditions | Permission Request | Trademarks
BD Worldwide
BD
1 Becton Drive
Franklin Lakes, NJ USA 07417
201.847.6800
Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2009 BD